Abstract
In the title complex, [Mn(C7H5O3)(C27H27N7)(C3H7NO)]ClO4·C3H7NO, the MnII ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris(1-methyl-1H-benzimidazol-2-ylmethyl)amine (Mentb) ligand coordinates in a tetradentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethylformamide ligand. The hydroxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites with occupancies of 0.581 (8) and 0.419 (8). Both disorder components of the hydroxy group form intramolecular O—H⋯O hydrogen bonds.
Highlights
In the title complex, [Mn(C7H5O3)(C27H27N7)(C3H7NO)]ClO4C3H7NO, the MnII ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry
The tris(1methyl-1H-benzimidazol-2-ylmethyl)amine (Mentb) ligand coordinates in a tetradentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethylformamide ligand
The hydroxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites with occupancies of 0.581 (8) and 0.419 (8)
Summary
Key indicators: single-crystal X-ray study; T = 296 K; mean (C–C) = 0.005 Å; disorder in main residue; R factor = 0.052; wR factor = 0.163; data-to-parameter ratio = 14.1. In the title complex, [Mn(C7H5O3)(C27H27N7)(C3H7NO)]ClO4C3H7NO, the MnII ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris(1methyl-1H-benzimidazol-2-ylmethyl)amine (Mentb) ligand coordinates in a tetradentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethylformamide ligand. The hydroxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites with occupancies of 0.581 (8) and 0.419 (8). Both disorder components of the hydroxy group form intramolecular O—
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have